Guangdong Xin Nanfang Qinghao Pharmaceutical Co. Ltd.

1. This study selected healthy subjects as test subjects to investigate the tolerance of artemisinin sulfate hydroxychloroquine tablets to healthy subjects and determine the maximum tolerated dose (MTD). 2. Evaluate the pharmacokinetic (PK) characteristics of artemisinin sulfate hydroxychloroquine tablets in healthy subjects after single administration.

1. Using placebo as control, preliminarily evaluate the efficacy and safety of Lianmei Granules in the treatment of patients with type 2 diabetes (Qi and Yin deficiency syndrome). 2. Explore the reasonable dose of Lianmei Granules in the treatment of patients with type 2 diabetes (Qi and Yin deficiency syndrome) to provide a basis for Phase III clinical trials.